Chief, Division of Neurocritical Care Neurology, Massachusetts General Hospital

Clinicn Investigator, Assc Prf Center for Genomic Medicine, Mass General Research Institute

Associate Professor of Neurology Harvard Medical School

Associate Neurologist Neurology, Massachusetts General Hospital

MD Harvard Medical School 2004

MSc Harvard Medical School 2012

amino acids, branched-chain; amyloid beta-protein precursor; amyloid precursor protein secretases; aspartic acid endopeptidases; brain edema; brain ischemia; cerebral infarction; critical care; critical illness; endopeptidases; glyburide; hypoglycemic agents; intensive care; matrix metalloproteinase 9; membrane proteins; stroke Neurological disease takes a unique and tragic toll on our patients. The Kimberly Lab is committed to reducing the devastating effects of acute brain injury by focusing on translational studies that bridge basic science and clinical research. We believe that therapeutic discovery is not a linear path from fundamental mechanism to new drug, but instead a cycle that requires bi-directional and multidisciplinary integration of basic and patient-oriented research. A presence at each stage of discovery—both directly and through strategic collaboration—is central to our mission to advancing new treatments. Consequently, our laboratory is highly multidisciplinary and collaborative, and our work could not be accomplished without our collaborative partners.